was read the article
array:23 [ "pii" => "S1988885617300949" "issn" => "19888856" "doi" => "10.1016/j.recote.2017.12.005" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "697" "copyright" => "SECOT" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2018;62:86-92" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1888441517301352" "issn" => "18884415" "doi" => "10.1016/j.recot.2017.08.001" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "697" "copyright" => "SECOT" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Rev Esp Cir Ortop Traumatol. 2018;62:86-92" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 113 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 95 "PDF" => 13 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">INVESTIGACIÓN</span>" "titulo" => "Nuevo método de liberación de antibióticos del cemento óseo (polimetilmetacrilato): redefiniendo los límites" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "86" "paginaFinal" => "92" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "New method for antibiotic release from bone cement (polymethylmethacrylate): Redefining boundaries" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 978 "Ancho" => 1305 "Tamanyo" => 155276 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Probetas de cemento para los ensayos de dureza (de izquierda a derecha: cemento control, con rifampicina, con microcápsulas de PHBV y con microcápsulas de alginato).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "E. Carbó-Laso, P. Sanz-Ruiz, J.C. del Real-Romero, Y. Ballesteros-Iglesias, E. Paz-Jiménez, F. Arán-Ais, M. Sánchez-Navarro, M.A. Pérez-Limiñana, I. López-Torres, J. Vaquero-Martín" "autores" => array:10 [ 0 => array:2 [ "nombre" => "E." "apellidos" => "Carbó-Laso" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Sanz-Ruiz" ] 2 => array:2 [ "nombre" => "J.C." "apellidos" => "del Real-Romero" ] 3 => array:2 [ "nombre" => "Y." "apellidos" => "Ballesteros-Iglesias" ] 4 => array:2 [ "nombre" => "E." "apellidos" => "Paz-Jiménez" ] 5 => array:2 [ "nombre" => "F." "apellidos" => "Arán-Ais" ] 6 => array:2 [ "nombre" => "M." "apellidos" => "Sánchez-Navarro" ] 7 => array:2 [ "nombre" => "M.A." "apellidos" => "Pérez-Limiñana" ] 8 => array:2 [ "nombre" => "I." "apellidos" => "López-Torres" ] 9 => array:2 [ "nombre" => "J." "apellidos" => "Vaquero-Martín" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1988885617300949" "doi" => "10.1016/j.recote.2017.12.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885617300949?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888441517301352?idApp=UINPBA00004N" "url" => "/18884415/0000006200000001/v1_201801180601/S1888441517301352/v1_201801180601/es/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S1988885617300950" "issn" => "19888856" "doi" => "10.1016/j.recote.2017.12.006" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "698" "copyright" => "SECOT" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Esp Cir Ortop Traumatol. 2018;62:80-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>" "titulo" => "Resurfacing arthroplasty as an alternative to the posttraumatic sequelae of fractures of the external column of the humerus in the young adult" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "80" "paginaFinal" => "85" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Artroplastia de resuperficialización como alternativa a las secuelas postraumáticas de la columna externa del húmero en el adulto joven" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3462 "Ancho" => 2167 "Tamanyo" => 650174 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">From left to right and from top to bottom: (A and B) lateral and AP X-ray images of the fracture. (C and D) CT images of the fracture. (E and F) Lateral and AP X-ray images of the osteosynthesis 6 days later.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Aroca-Peinado, D. Cecilia-López, V. Jiménez-Díaz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Aroca-Peinado" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Cecilia-López" ] 2 => array:2 [ "nombre" => "V." "apellidos" => "Jiménez-Díaz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1888441517301364" "doi" => "10.1016/j.recot.2017.09.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1888441517301364?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885617300950?idApp=UINPBA00004N" "url" => "/19888856/0000006200000001/v1_201801220510/S1988885617300950/v1_201801220510/en/main.assets" ] "en" => array:21 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Research</span>" "titulo" => "New method for antibiotic release from bone cement (polymethylmethacrylate): Redefining boundaries" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "86" "paginaFinal" => "92" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "E. Carbó-Laso, P. Sanz-Ruiz, J.C. del Real-Romero, Y. Ballesteros-Iglesias, E. Paz-Jiménez, F. Arán-Ais, M. Sánchez-Navarro, M.A. Pérez-Limiñana, I. López-Torres, J. Vaquero-Martín" "autores" => array:10 [ 0 => array:4 [ "nombre" => "E." "apellidos" => "Carbó-Laso" "email" => array:1 [ 0 => "esthercarbolaso@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "P." "apellidos" => "Sanz-Ruiz" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "J.C." "apellidos" => "del Real-Romero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Y." "apellidos" => "Ballesteros-Iglesias" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 4 => array:3 [ "nombre" => "E." "apellidos" => "Paz-Jiménez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 5 => array:3 [ "nombre" => "F." "apellidos" => "Arán-Ais" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 6 => array:3 [ "nombre" => "M." "apellidos" => "Sánchez-Navarro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 7 => array:3 [ "nombre" => "M.A." "apellidos" => "Pérez-Limiñana" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 8 => array:3 [ "nombre" => "I." "apellidos" => "López-Torres" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 9 => array:3 [ "nombre" => "J." "apellidos" => "Vaquero-Martín" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Servicio de Cirugía Ortopédica y Traumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Cirugía, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Departamento de Ingeniería Mecánica, Instituto de Investigación en Tecnología, Universidad Pontificia Comillas, Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Departamento de Microencapsulación y Nanotecnología, Instituto Tecnológico del Calzado y Conexas (INESCOP), Elda, Alicante, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding Author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nuevo método de liberación de antibióticos del cemento óseo (polimetilmetacrilato): redefiniendo los límites" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1296 "Ancho" => 2339 "Tamanyo" => 103950 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Resistance to compression of cement samples. *The regulation ISO 5833:2002 establishes a minimum compression resistance of 70<span class="elsevierStyleHsp" style=""></span>MPa for acrylic cements.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Periprosthetic joint infection is a serious complication, the prevalence of which has risen in the last few decades. It has been estimated that this will be the most common cause of prosthetic revision surgery in the next 2 or 3 decades.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,2</span></a> The appearance of multi-resistant germs and the medical complexity of patients have imposed modification of existing surgical protocols which are insufficient for optimum management of such a complex problem, in addition to investigating new forms of treatment.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The majority of microorganisms which cause periprosthetic infection are producers of biofilm. The bacteria inside the biofilm radically change their phenotype leading to bacterial growth with a metabolically low activity and enabling bacteria to survive during chronic infection.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">3</span></a> This means that in conditions of mature biofilm, the active in vitro doses of the antibiotic are 200–1000 times higher than the standard dosis,<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">4</span></a> making it impossible to treat periprosthetic infections with antibiotics alone, administered systemically. Elevated concentrations of antibiotic on the infection site raises the probability of success of the treatment and this may be achieved through the use of antibiotic-impregnated cement spacers.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The two-stage exchange arthroplasty is considered to be the gold standard treatment for chronic periprosthetic infection. After the removal of the joint prosthesis and debridement of infected tissues, a bone cement spacer is temporally inserted with a high dose of antibiotics aimed at preserving the joint space and achieving high local levels of antibiotics. Amino glucosides and vancomycin are the most commonly used antibiotics added to the bone cement, but the appearance of multi-resistant strains of bacteria is threatening their efficacy in local treatment.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The role of rifampicin against staphylococcal infections associated with implants has been demonstrated.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">6</span></a> Rifampicin, in combination with other antibiotics is considered to be the antibiotic of choice in the treatment of staphylococcal infections associated with joint replacements due to its bacterial activity against stationary phase bacteria, its intracellular activity and its capacity for diffusion in biofilm.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">7</span></a> Theoretically, its topical use on periprosthetic tissues would offer advantages but the addition of rifampicin to polymethylmethacrylate (PMMA) delays the polymerisation of the cement preventing its use for the manufacture of spacers. The proposed mechanism is that the rifampicin reacts with benzoyl peroxide (initiator) and/or with N,N-dimethyl-p-toluidine (activator), preventing the formation of benzoil radicals and from them forming covalent bonds in the methylmethacrylate.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The aim of this experimental study was the isolation of rifampicin during the PMMA polymerisation process using microencapsulation techniques to preserve the mechanical properties and setting time of the bone cement.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Microcapsule synthesis process</span><p id="par0030" class="elsevierStylePara elsevierViewall">Microcapsules of rifampicin were synthesised with alginate and polyhydroxybutyrate (PHBV) using ionic jellification and evaporation of the solvent, respectively and using rifampicin, the trade name of which is Rifaldin<span class="elsevierStyleSup">®</span> (Sanofi, Barcelona, Spain).</p><p id="par0035" class="elsevierStylePara elsevierViewall">Ionic jellification is based on the ability of the alginate to reticulate and form hydrogels in the presence of counter ions (CaCl<span class="elsevierStyleInf">2</span> and chitosan). The alginate and rifampicin were added drop by drop, under constant agitation, to a solution with counter ions, forming complexes between the opposing load species and producing microcapsules which were collected by filtration.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The evaporation method of the solvent consisted in forming an emulsion whose internal phase was dissolved PHBV in an organic solvent with the rifampicin. After the organic phase this was dispersed into the watery solution which contained the surfactant. Once the emulsion had been formed, it was homogenised and the solvent evaporated to achieve the gradual precipitation of the PHBV with rifampicin.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The micro particles obtained were analysed with a scanning electron microscope. The morphology of the micro particles was spherical in the PHBV samples and irregular in the alginate particles. Eight samples of PHBV microcapsules and 4 of alginate were synthesised.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Traits of the microcapsules</span><p id="par0050" class="elsevierStylePara elsevierViewall">To determine the rifampicin content of the PHBV microcapsules we dissolved 5<span class="elsevierStyleHsp" style=""></span>mg of each sample in 5<span class="elsevierStyleHsp" style=""></span>ml of a solution of dichloromethane and methanol (10%/90%). In the case of alginate, we used a solution of 0.25<span class="elsevierStyleHsp" style=""></span>M ethylene diamine tetra acetate since the alginate does not dissolve in dichloromethane and ethanol. To process the total dilution of the microcapsules, they were centrifuged at 4000<span class="elsevierStyleHsp" style=""></span>rpm for 5<span class="elsevierStyleHsp" style=""></span>min. The supernatant was analysed using visible ultraviolet spectrophotometry (Agilent Technologies, Santa Clara, CA, U.S.A.), with a previous construction of the calibrated curve of rifampicin at a wavelength of 334<span class="elsevierStyleHsp" style=""></span>nm. Each sample was analysed in triplicate.</p><p id="par0055" class="elsevierStylePara elsevierViewall">The microencapsulation process was characterised using 3 parameters: efficiency of rifampicin encapsulation or rifampicin content (% Rifampicin), performance of microcapsule production (<span class="elsevierStyleItalic">η</span><span class="elsevierStyleInf">MIC</span>) and performance of rifampicin microencapsulation (<span class="elsevierStyleItalic">η</span><span class="elsevierStyleInf">RIF</span>). The rifampicin content was defined as the quotient between the microensapculated rifampicin mass and the microcapsule mass obtained. The performance of microcapsule production was determined as the quotient between the microcapsule mass obtained and the mass of the quotient. The performance of the rifampicin microencapsulation was calculated as the quotient between the microencapsulated mass of rifampicin and the mass of rifampicin used.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Preparation of cement sample and mechanical trials</span><p id="par0060" class="elsevierStylePara elsevierViewall">The cement was manually prepared in accordance with international standards ASTM F451:99 (Standard Specification for Acrylic Bone Cement)<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">9</span></a> and ISO 5833:2002 (Implants for surgery-Acrylic resin cements).<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">10</span></a> The commercial cement CMW<span class="elsevierStyleSup">®</span>1 (DePuy International Ltd., Blackpool, United Kingdom) was used. Samples with rifampicin (1.25% P/P) and microcapsules (5% P/P) were prepared following the recommendations of Frommelt to gain homogeneous distribution of the antibiotic. Control samples of cement without antibiotic were also prepared.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Cylindrical test tubes were made measuring 12.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1<span class="elsevierStyleHsp" style=""></span>mm in height and 6.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1<span class="elsevierStyleHsp" style=""></span>mm in diameter for compression tests (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>), in compliance with regulation ISO 5833:2002. We obtained between 4 and 6 test tubes for each sample. These were tested with the universal trial machine ELIB 20W<span class="elsevierStyleSup">®</span> (Ibertest, Madrid, Spain) one week after their production, at a compression speed of 20<span class="elsevierStyleHsp" style=""></span>mm/min and with a load cell of 20<span class="elsevierStyleHsp" style=""></span>kN.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">To study hardness, rectangular test tubes were made measuring 80.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1<span class="elsevierStyleHsp" style=""></span>mm in length, 10.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1<span class="elsevierStyleHsp" style=""></span>mm in width and 4.0<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.1<span class="elsevierStyleHsp" style=""></span>mm in height (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>), according to the UNE-ISO 7619-1:2011 international standard (vulcanised rubber and thermoplastic. Determination of indentation toughness).<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> The shore Bareiss<span class="elsevierStyleSup">®</span> (Neurtek, Eibar, Spain) hardness tester was used to determine hardness at 15, 30, 45 and 60<span class="elsevierStyleHsp" style=""></span>min, and at 2, 3, 4 and 24<span class="elsevierStyleHsp" style=""></span>h, in 3 test tubes of each sample.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">The data are presented as a mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation. Statistical analysis was performed suing version 22.0 SPSS<span class="elsevierStyleSup">®</span> (SPSS Inc., Chicago, IL, U.S.A.), using the ANOVA test for repeated means and the post hoc Bonferroni analysis. <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was defined as statistically significant.</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><p id="par0080" class="elsevierStylePara elsevierViewall">The percentage of rifampicin, performance of microcapsule production and performance of rifampicin microencapsulation were higher with alginate than with PHBV, as is shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>, with differences being statistically significant (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0001).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0085" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a> shows the resistance to compression of the samples studied. The test tubes with of cement with PHBV and alginate microcapsules and alginate showed lower reduction in resistance to compression (reduction of 14% with respect to cement control) than the cement with non-encapsulated rifampicin (reduction of 30% compared with the cement). The data obtained from the trial are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>. Significant statistical differences were detected in on comparing the mean values of resistance to compression between the rifampicin control cement, the alginate control, the PHBV-control, PHBV-rifampicin and alginate-rifampicin (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0001 in all comparisons). No statistical significance was reached on comparing PHBV and alginate (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1).</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">The hardness curve obtained with the cement with microcapsules of alginate was similar to that of the control cement at all the times studied (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>), reaching its maximum hardness after 15<span class="elsevierStyleHsp" style=""></span>min (73 H<span class="elsevierStyleInf">D</span>). Cement setting time with non-encapsulated rifampicin was greater than that of the cement with microencapsulated rifampicin and the control cement. The cement with non-encapsulated rifampicin could not be tested at 15<span class="elsevierStyleHsp" style=""></span>min because it was still too liquid. It began to harden after 30<span class="elsevierStyleHsp" style=""></span>min (33 H<span class="elsevierStyleInf">D</span>) and did not achieve a similar hardness to the control cement until after 45<span class="elsevierStyleHsp" style=""></span>min (67 H<span class="elsevierStyleInf">D</span>).</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Discussion</span><p id="par0095" class="elsevierStylePara elsevierViewall">There is a growing interest in adding antibiotics with elevated anti-staphylococcal activity to bone cement due to the concern in the increase in bacterial resistance to standard antibiotics. Linezolid and several quinolones such as levofloxacin have already been used in in vitro studies.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,13</span></a> However, the addition of rifampicin to PMMA prevents it complete polymerisation producing a sticky black material which is unsuitable for medical practice, despite having demonstrated to be a good at in vitro elution, and active against S. aureus.<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">5,8,14</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">The first people to microencapsulate an antibiotic to add it to PMMA were Shi et al.,<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> who described the manufacture of colistin microspheres with polylactic acid to control the release of the PMA antibiotic used in craniofacial bone defects. Since then there have been no references in the literature to antibiotic microencapsulation in PMMA.</p><p id="par0105" class="elsevierStylePara elsevierViewall">Rifampicin had already been previously encapsulated for its use in the treatment of pulmonary tuberculosis. The polymers used were PHBV, alginate, colistin with polylactic acid and also liposomes and lipids.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">16–20</span></a> However, the use of microencapsulated rifampicin in bone cement aimed at the preservation of mechanical properties and setting characteristics has not been studied.</p><p id="par0110" class="elsevierStylePara elsevierViewall">There is a need for between 5% and 10% P/P of antibiotic to obtain good levels of elution of bone cement antibiotic and thus achieve local therapeutic levels. However, the addition of elevated doses of antibiotics to the bone cement impairs its mechanical properties. He et al.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">21</span></a> studied the mechanical changes after adding 1<span class="elsevierStyleHsp" style=""></span>g (2.4% P/P), 2<span class="elsevierStyleHsp" style=""></span>g (4.8% P/P), 4<span class="elsevierStyleHsp" style=""></span>g (9.1% P/P) and 6<span class="elsevierStyleHsp" style=""></span>g (13% P/P) of gentamicin to the cement Palacos<span class="elsevierStyleSup">®</span>, recommended to a maximum of 6.5% P/P of antibiotic for maintaining the properties of cement compression. Lautenschlager et al.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">22</span></a> estimated that the addition of 4.5<span class="elsevierStyleHsp" style=""></span>g of gentamicin by 40<span class="elsevierStyleHsp" style=""></span>g (10.1% P/P) would reduce the compression force to below 70<span class="elsevierStyleHsp" style=""></span>MPa. Rifampicin, even in lower concentrations to those recommended for the manufacture of cement spacers seriously impairs the PMMA properties. In 1982, De Palma et al. were the first to refer to the inhibition of complete polymerisation of CMW<span class="elsevierStyleSup">®</span> bone cement when rifampicin was added.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">23</span></a> Anguita-Alonso et al.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">5</span></a> and Gálvez-López et al.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">24</span></a> recently recognised the benefits of obtaining a cement which released rifampicin in the treatment of periprosthetic infection, but they experienced the same problem with regards to the setting delay. In our mechanical trials, compression resistance of the cement with 1.25% P/P of rifampicin (0.5<span class="elsevierStyleHsp" style=""></span>g of rifampicin per 40<span class="elsevierStyleHsp" style=""></span>g) was 74.04<span class="elsevierStyleHsp" style=""></span>MPa, and that of the cement with 5% P/P of microcapsules (0.035 or 0.10<span class="elsevierStyleHsp" style=""></span>g of rifampicin per 40<span class="elsevierStyleHsp" style=""></span>g) was 91.26 and 91.35<span class="elsevierStyleHsp" style=""></span>MPa in the PHBV microcapsules or alginate, respectively. There are no data in the references on resistance to PMMA compression with rifampicin.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Our study is the first one to offer a solution to the problem of the delayed setting time of PMMA on the addition of rifampicin. The polymerisation of the cement with non-encapsulated rifampicin took 45<span class="elsevierStyleHsp" style=""></span>min, and exceeded the time which is normally available in the operating theatre for manufacture of cement spacers. However, microencapsulation with alginate gave us setting times which were equivalent to those of the control cement. Longer setting times, 122.5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>31.1<span class="elsevierStyleHsp" style=""></span>min, have been published after adding 1, 2 and 4<span class="elsevierStyleHsp" style=""></span>g of rifampicin or a combination of 1<span class="elsevierStyleHsp" style=""></span>g de rifampicin+1<span class="elsevierStyleHsp" style=""></span>g of isoniazide, or 2<span class="elsevierStyleHsp" style=""></span>g of rifampicin<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>2<span class="elsevierStyleHsp" style=""></span>g of isoniazide to the CMW<span class="elsevierStyleSup">®</span>3<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> cement. The results obtained indicate that microencapsulation could be an appropriate technique for isolating rifampicin during the PMMA polymerisation process, leading to its complete setting in a reasonable amount of time.</p><p id="par0120" class="elsevierStylePara elsevierViewall">The main limitation of our study is that it was in vitro, which may not reflect in vivo conditions exactly. Further animal trials would be needed to become better acquainted with the effects of the cement with rifampicin in prosthetic infection. Another limitation is that all trials were conducted as monotherapy. It is well known that the use of rifampicin in monotherapy is not recommended due to the high risk of developing resistance. The synergy study of rifampicin with other antibiotics commonly used in bone cement, such as gentamicin or vancomicin, form part of our future research investigations. Neither was there any determination of the rifampicin release kinetics from the cement with microcapsules, since this did not form part of the objective of the initial stage of the study, which was to achieve the addition of rifampicin to PMMA.</p><p id="par0125" class="elsevierStylePara elsevierViewall">The essential clinical application derived from this experimental study is the possibility of obtaining a bone cement which contains rifampicin, whilst preserving several valid mechanical properties for manufacturing cement spacers. The benefits of obtaining high local concentrations of rifampicin in the periprosthetic infection site are indubitable. The ionic jellification of alginate would be the microencapsulation technique of rifampicin with the most advantages with regards to setting time and PMMA compression properties.</p><p id="par0130" class="elsevierStylePara elsevierViewall">The trials carried out in our study may be the starting point for the study of whether microencapsulation would offer advantages in the case of commonly used antibiotics in bone cement, enabling mechanical properties to be preserved despite an increase in concentration. Along these same lines, encapsulation could offer an advantage against other antibiotics whose addition to bone cement is disadvantageous, such as amphotericin,<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">25</span></a> and in the spreading of tumour-inducing agents in bone metastases.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">26</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">To conclude, microencapsulation with alginate is the best technique for introducing rifampicin in the PMMA, since the properties of compression and setting time are preserved.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Level of evidence</span><p id="par0140" class="elsevierStylePara elsevierViewall">Level of evidence I<span class="elsevierStyleSmallCaps">.</span></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Ethical disclosures</span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Protection of human and animal subjects</span><p id="par0145" class="elsevierStylePara elsevierViewall">The authors declare that no experiments have been performed on humans or animals in this research.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Confidentiality of data</span><p id="par0150" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Right to privacy and informed consent</span><p id="par0155" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Funding</span><p id="par0160" class="elsevierStylePara elsevierViewall">This project was financed thanks to the <span class="elsevierStyleGrantSponsor" id="gs1">Initial Research Project in Orthopaedic Surgery and Orthopaedics Grant</span>, awarded by the Sociedad Española de Cirugía Ortopédica y Traumatología (SECOT), 2015. The title of the project was: “Experimental Study of rifampicin elution of bone cement (polymethylmethacrylate.” Main author: Esther Carbó Laso. Colaborators: Pablo Sanz Ruiz; Francisco Javier Vaquero Martín. Centre of work: Hospital Universitario Gregorio Marañón, Madrid.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Conflict of interest</span><p id="par0165" class="elsevierStylePara elsevierViewall">We state there are no conflicts of interests.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:3 [ "identificador" => "xres972072" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and method" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Discussion and conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec942636" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres972071" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y método" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Discusión y conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec942635" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Microcapsule synthesis process" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Traits of the microcapsules" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Preparation of cement sample and mechanical trials" ] ] ] 6 => array:2 [ "identificador" => "sec0030" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0035" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0040" "titulo" => "Level of evidence" ] 9 => array:3 [ "identificador" => "sec0045" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0050" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0055" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0060" "titulo" => "Right to privacy and informed consent" ] ] ] 10 => array:2 [ "identificador" => "sec0065" "titulo" => "Funding" ] 11 => array:2 [ "identificador" => "sec0070" "titulo" => "Conflict of interest" ] 12 => array:2 [ "identificador" => "xack329332" "titulo" => "Acknowledgements" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-03-01" "fechaAceptado" => "2017-08-30" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec942636" "palabras" => array:5 [ 0 => "Rifampicin" 1 => "Polymethylmethacrylate" 2 => "Microcapsules" 3 => "Cement spacers" 4 => "Periprosthetic infection" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec942635" "palabras" => array:5 [ 0 => "Rifampicina" 1 => "Polimetilmetacrilato" 2 => "Microcápsulas" 3 => "Espaciadores de cemento" 4 => "Infección periprotésica" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The increasing antimicrobial resistance is promoting the addition of antibiotics with high antistaphylococcal activity to polymethylmethacrylate (PMMA), for use in cement spacers in periprosthetic joint infection. Linezolid and levofloxacin have already been used in in vitro studies, however, rifampicin has been shown to have a deleterious effect on the mechanical properties of PMMA, because it inhibits PMMA polymerisation. The objective of our study was to isolate the rifampicin during the polymerisation process using microencapsulation techniques, in order to obtain a PMMA suitable for manufacturing bone cement spacers.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Material and method</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Microcapsules of rifampicin were synthesised with alginate and PHBV, using Rifaldin<span class="elsevierStyleSup">®</span>. The concentration levels of rifampicin were studied by UV–vis spectrophotometry. Compression, hardness and setting time tests were performed with CMW<span class="elsevierStyleSup">®</span>1 cement samples alone, with non-encapsulated rifampicin and with alginate or PHBV microcapsules.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The production yield, efficiency and microencapsulation yield were greater with alginate (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0001). The cement with microcapsules demonstrated greater resistance to compression than the cement with rifampicin (91.26<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.13, 91.35<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.29 and 74.04<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.57<span class="elsevierStyleHsp" style=""></span>MPa in alginate, PHBV and rifampicin, respectively) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.0001). The setting time reduced, and the hardness curve of the cement with alginate microcapsules was similar to that of the control.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discussion and conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Microencapsulation with alginate is an appropriate technique for introducing rifampicin into PMMA, preserving compression properties and setting time. This could allow intraoperative manufacturing of bone cement spacers that release rifampicin for the treatment of periprosthetic joint infection.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Material and method" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Discussion and conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducción</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La creciente resistencia a antimicrobianos está impulsando la adición de antibióticos con elevada actividad antiestafilocócica al polimetilmetacrilato (PMMA), para su uso en los espaciadores de cemento en la infección periprotésica. El linezolid o el levofloxacino ya han sido utilizados en estudios in vitro; sin embargo, la rifampicina ha demostrado un efecto deletéreo sobre las propiedades mecánicas del PMMA, inhibiendo su polimerización. El objetivo de nuestro estudio fue aislar la rifampicina durante el proceso de polimerización mediante técnicas de microencapsulación, con el fin de obtener un PMMA apto para la fabricación de espaciadores articulares.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Material y método</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se sintetizaron microcápsulas de rifampicina con alginato y PHBV, utilizando Rifaldin<span class="elsevierStyleSup">®</span>. Se estudió la concentración de rifampicina mediante espectrofotometría UV-visible. Se realizaron ensayos de compresión, dureza y tiempo de fraguado con probetas de cemento CMW<span class="elsevierStyleSup">®</span>1 solo, con rifampicina y microcápsulas de PHBV y alginato.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">El rendimiento de producción, la eficiencia y el rendimiento de microencapsulación fueron mayores con alginato (p = 0,0001). El cemento con microcápsulas mostró mayor resistencia a la compresión que el cemento con rifampicina (91,26 ± 5,13, 91,35 ± 6,29 y 74,04 ± 3,57<span class="elsevierStyleHsp" style=""></span>MPa en alginato, PHBV y rifampicina, respectivamente) (p = 0,0001). El tiempo de fraguado disminuyó, siendo la curva de dureza del cemento con microcápsulas de alginato similar a la de control.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Discusión y conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La microencapsulación con alginato es una técnica adecuada para introducir rifampicina en el PMMA preservando las propiedades de compresión y el tiempo de fraguado. Su obtención permitiría fabricar espaciadores que liberasen localmente rifampicina para el tratamiento de la infección periprotésica.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Material y método" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Discusión y conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Carbó-Laso E, Sanz-Ruiz P, del Real-Romero JC, Ballesteros-Iglesias Y, Paz-Jiménez E, Arán-Ais F, et al. Nuevo método de liberación de antibióticos del cemento óseo (polimetilmetacrilato): redefiniendo los límites. Rev Esp Cir Ortop Traumatol. 2018;62:86–92.</p>" ] ] "multimedia" => array:6 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 736 "Ancho" => 2333 "Tamanyo" => 154468 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Cement test tubes for compression trials (from left to right: control cement, with rifampicin, with PHBV microcapsules and with alginate microcapsules).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 978 "Ancho" => 1305 "Tamanyo" => 156148 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Cement test tubes for hardness trails (from left to right: control cement, with rifampicin, with PHBV microcapsules and with alginate microcapsules).</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1296 "Ancho" => 2339 "Tamanyo" => 103950 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Resistance to compression of cement samples. *The regulation ISO 5833:2002 establishes a minimum compression resistance of 70<span class="elsevierStyleHsp" style=""></span>MPa for acrylic cements.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1782 "Ancho" => 2522 "Tamanyo" => 211007 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Hardness acquired over time by the different cement samples (in units of hardness).</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Polymer \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Starting reagents \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">% Encapsulated rifampicin \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Production performance (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Microencapsulation performance (%) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PHBV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PHBV: 0.92<span class="elsevierStyleHsp" style=""></span>g<br>Rif: 0.11<span class="elsevierStyleHsp" style=""></span>g<br>Mass obtained: 0.73<span class="elsevierStyleHsp" style=""></span>g \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.75<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">70.51<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6.51 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.13<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.19 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Alginate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Alginate: 1.50<span class="elsevierStyleHsp" style=""></span>g<br>Rif: 0.20<span class="elsevierStyleHsp" style=""></span>g<br>Mass obtained: 2.32<span class="elsevierStyleHsp" style=""></span>g \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.33<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.47 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">135.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>16.31 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60.03<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.19 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1644869.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Mean values and standard deviation of the percentage of encapsulated rifampicin, production performance and microencapsulation of the 8 samples of PHBV microcapsules and the 4 alginate capsules.</p>" ] ] 5 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Resistance to compression (MPa) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Standard deviation \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Control \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">106.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.97 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Rifampicin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">74.04 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.57 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PHBV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">91.26 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.13 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Alginate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">91.35 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.29 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1644870.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Mean values and standard deviation of the resistance to compression of the control cements, with non encapsulated rifampicin, with PHBV microcapsules and with alginate microcapsules.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib0135" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New developments in diagnosis and treatment of infection in orthopedic implants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A.F. Widmer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/321863" "Revista" => array:7 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2001" "volumen" => "33" "numero" => "Suppl. 2" "paginaInicial" => "S94" "paginaFinal" => "S106" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11486305" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0140" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The epidemiology of revision total knee arthroplasty in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.J. Bozic" 1 => "S.M. Kurtz" 2 => "E. Lau" 3 => "K. Ong" 4 => "V. Chiu" 5 => "T.P. Vail" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11999-009-0945-0" "Revista" => array:6 [ "tituloSerie" => "Clin Orthop Relat Res" "fecha" => "2010" "volumen" => "468" "paginaInicial" => "45" "paginaFinal" => "51" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19554385" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0145" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biomaterial-centered infection: microbial adhesion versus tissue integration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A.G. Gristina" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "1987" "volumen" => "237" "paginaInicial" => "1588" "paginaFinal" => "1595" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3629258" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0150" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. François" 1 => "P. Vaudaux" 2 => "P.D. Lew" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s100169900112" "Revista" => array:6 [ "tituloSerie" => "Ann Vasc Surg" "fecha" => "1998" "volumen" => "12" "paginaInicial" => "34" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9451994" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0155" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative study of antimicrobial release kinetics from polymethylmethacrylate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Anguita-Alonso" 1 => "M.S. Rouse" 2 => "K.E. Piper" 3 => "D.J. Jacofsky" 4 => "D.R. Osmon" 5 => "R. Patel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.blo.0000201167.90313.40" "Revista" => array:6 [ "tituloSerie" => "Clin Orthop Relat Res" "fecha" => "2006" "volumen" => "445" "paginaInicial" => "239" "paginaFinal" => "244" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16474225" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0160" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Foreign-Body Infection (FBI) Study Group" "etal" => false "autores" => array:5 [ 0 => "W. Zimmerli" 1 => "A.F. Widmer" 2 => "M. Blatter" 3 => "R. Frei" 4 => "P.E. Ochsner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1998" "volumen" => "279" "paginaInicial" => "1537" "paginaFinal" => "1541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9605897" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0165" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D.P. Konig" 1 => "J.M. Schierholz" 2 => "U. Munnich" 3 => "J. Rutt" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Orthop Trauma Surg" "fecha" => "2001" "volumen" => "121" "paginaInicial" => "297" "paginaFinal" => "299" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11409564" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0170" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Deactivation of Palacos R bone cement with the addition of rifampin antibiotic powder. An in-vivo experience. Case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E.J. McPherson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Reconstr Rev" "fecha" => "2011" "volumen" => "1" "paginaInicial" => "34" "paginaFinal" => "36" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0175" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "Available from: <span class="elsevierStyleInterRef" id="intr0010" href="https://www.document-center.com/standards/show/ASTM-F451/history/1986%20EDITION">https://www.document-center.com/standards/show/ASTM-F451/history/1986%20EDITION</span> [accessed 12.10.17]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standard specification for acrylic bone cement (ASTM F451-99a)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Materials ASfTa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "1999" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0180" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ISO 5833:2002. Implants for surgery – acrylic resin cements" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "International Organization for Standardization" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2002" "editorial" => "Technical Committee ISO/TC 150, Implants for Surgery, Subcommittee SC 1, Materials" "editorialLocalizacion" => "Suiza" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0185" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Caucho vulcanizado o termoplástico. Determinación de la dureza de indentación. Parte 1: Método del durómetro (dureza Shore)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "UNE-ISO 7619-1:2011" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2011" "editorial" => "AENOR" "editorialLocalizacion" => "Madrid" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0190" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enhancement of antibiotic elution from acrylic bone cement" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Anagnostakos" 1 => "J. Kelm" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbm.b.31281" "Revista" => array:6 [ "tituloSerie" => "J Biomed Mater Res B Appl Biomater" "fecha" => "2009" "volumen" => "90" "paginaInicial" => "467" "paginaFinal" => "475" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19145626" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0195" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.C. Matos" 1 => "C.F. Marques" 2 => "R.V. Pinto" 3 => "I.A. Ribeiro" 4 => "L.M. Gonçalves" 5 => "M.A. Vaz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijpharm.2015.05.038" "Revista" => array:6 [ "tituloSerie" => "Int J Pharm" "fecha" => "2015" "volumen" => "490" "paginaInicial" => "200" "paginaFinal" => "208" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26002570" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0200" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: An in vitro study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.D. Han" 1 => "T. Oh" 2 => "S.N. Cho" 3 => "J.H. Yang" 4 => "K.K. Park" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11999-013-2899-5" "Revista" => array:6 [ "tituloSerie" => "Clin Orthop Relat Res" "fecha" => "2013" "volumen" => "471" "paginaInicial" => "2400" "paginaFinal" => "2406" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23504536" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0205" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Shi" 1 => "J.D. Kretlow" 2 => "A. Nguyen" 3 => "S. Young" 4 => "L. Scott Baggett" 5 => "M.E. Wong" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.biomaterials.2010.01.112" "Revista" => array:6 [ "tituloSerie" => "Biomaterials" "fecha" => "2010" "volumen" => "31" "paginaInicial" => "4146" "paginaFinal" => "4156" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20153893" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0210" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N. Duran" 1 => "M.A. Alvarenga" 2 => "E.C. da Silva" 3 => "P.S. Melo" 4 => "P.D. Marcato" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12272-001-2137-7" "Revista" => array:6 [ "tituloSerie" => "Arch Pharm Res" "fecha" => "2008" "volumen" => "31" "paginaInicial" => "1509" "paginaFinal" => "1516" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19023549" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0215" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Z. Ahmad" 1 => "S. Sharma" 2 => "G.K. Khuller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijantimicag.2005.07.012" "Revista" => array:6 [ "tituloSerie" => "Int J Antimicrob Agents" "fecha" => "2005" "volumen" => "26" "paginaInicial" => "298" "paginaFinal" => "303" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16154726" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0220" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Esmaeili" 1 => "M. Hosseini-Nasr" 2 => "M. Rad-Malekshahi" 3 => "N. Samadi" 4 => "F. Atyabi" 5 => "R. Dinarvand" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nano.2007.03.003" "Revista" => array:6 [ "tituloSerie" => "Nanomedicine" "fecha" => "2007" "volumen" => "3" "paginaInicial" => "161" "paginaFinal" => "167" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17468055" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0225" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prolonged release biodegradable vesicular carriers for rifampicin – formulation and kinetics of release" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.P. Kamath" 1 => "B.D. Shenoy" 2 => "S.B. Tiwari" 3 => "R. Karki" 4 => "N. Udupa" 5 => "M. Kotian" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Indian J Exp Biol" "fecha" => "2000" "volumen" => "38" "paginaInicial" => "113" "paginaFinal" => "118" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11218826" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0230" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lipid microsphere formulation containing rifampicin targets alveolar macrophages" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Takenaga" 1 => "Y. Ohta" 2 => "Y. Tokura" 3 => "A. Hamaguchi" 4 => "R. Igarashi" 5 => "A. Disratthakit" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/10717540801952530" "Revista" => array:6 [ "tituloSerie" => "Drug Deliv" "fecha" => "2008" "volumen" => "15" "paginaInicial" => "169" "paginaFinal" => "175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18379929" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0235" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of antibiotics on the properties of poly(methylmethacrylate)-based bone cement" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Y. He" 1 => "J.P. Trotignon" 2 => "B. Loty" 3 => "A. Tcharkhtchi" 4 => "J. Verdu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbm.10405" "Revista" => array:6 [ "tituloSerie" => "J Biomed Mater Res" "fecha" => "2002" "volumen" => "63" "paginaInicial" => "800" "paginaFinal" => "806" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12418027" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0240" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanical strength of acrylic bone cements impregnated with antibiotics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E.P. Lautenschlager" 1 => "G.W. Marshall" 2 => "K.E. Marks" 3 => "J. Schwartz" 4 => "C.L. Nelson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jbm.820100603" "Revista" => array:6 [ "tituloSerie" => "J Biomed Mater Res" "fecha" => "1976" "volumen" => "10" "paginaInicial" => "837" "paginaFinal" => "845" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/993222" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0245" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The mechanical properties of “cement-antibiotic” mixtures" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. De Palma" 1 => "F. Greco" 2 => "C. Ciarpaglini" 3 => "C. Caneva" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ital J Orthop Traumatol" "fecha" => "1982" "volumen" => "8" "paginaInicial" => "461" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7183664" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0250" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elution kinetics, antimicrobial activity, and mechanical properties of 11 different antibiotic loaded acrylic bone cement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Gálvez-López" 1 => "A. Pena-Monje" 2 => "R. Antelo-Lorenzo" 3 => "J. Guardia-Olmedo" 4 => "J. Moliz" 5 => "J. Hernández-Quero" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.diagmicrobio.2013.09.014" "Revista" => array:6 [ "tituloSerie" => "Diagn Microbiol Infect Dis" "fecha" => "2014" "volumen" => "78" "paginaInicial" => "70" "paginaFinal" => "74" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24231380" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0255" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elution and mechanical properties of antifungal bone cement" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B. Goss" 1 => "C. Lutton" 2 => "P. Weinrauch" 3 => "M. Jabur" 4 => "G. Gillett" 5 => "R. Crawford" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arth.2006.09.013" "Revista" => array:6 [ "tituloSerie" => "J Arthroplasty" "fecha" => "2007" "volumen" => "22" "paginaInicial" => "902" "paginaFinal" => "908" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17826283" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0260" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of adriamycin-impregnated methylmethacrylate in the treatment of tumor metastases in the long bones" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "H. Katagiri" 1 => "K. Sato" 2 => "M. Takahashi" 3 => "H. Sugiura" 4 => "S. Yamamura" 5 => "H. Iwata" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Orthop Trauma Surg" "fecha" => "1997" "volumen" => "116" "paginaInicial" => "329" "paginaFinal" => "333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9266034" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack329332" "titulo" => "Acknowledgements" "texto" => "<p id="par0170" class="elsevierStylePara elsevierViewall">We would like to thank Carmen de Pablos, student of the Mechanical Engineering Master's Degree of ICAI who collaborated in the undertaking of mechanical trials. Also to the Department of Microbiology of the Hospital General Universitario Gregorio Marañón, who supplied us with the means to conduct the microbiological trials.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/19888856/0000006200000001/v1_201801220510/S1988885617300949/v1_201801220510/en/main.assets" "Apartado" => array:4 [ "identificador" => "7585" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Research" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/19888856/0000006200000001/v1_201801220510/S1988885617300949/v1_201801220510/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1988885617300949?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 6 | 0 | 6 |
2024 October | 19 | 3 | 22 |
2024 September | 13 | 5 | 18 |
2024 August | 19 | 13 | 32 |
2024 July | 10 | 11 | 21 |
2024 June | 22 | 3 | 25 |
2024 May | 23 | 7 | 30 |
2024 April | 42 | 10 | 52 |
2024 March | 29 | 4 | 33 |
2024 February | 22 | 9 | 31 |
2024 January | 49 | 3 | 52 |
2023 December | 23 | 14 | 37 |
2023 November | 11 | 8 | 19 |
2023 October | 26 | 9 | 35 |
2023 September | 13 | 5 | 18 |
2023 August | 19 | 1 | 20 |
2023 July | 18 | 10 | 28 |
2023 June | 23 | 5 | 28 |
2023 May | 46 | 6 | 52 |
2023 April | 33 | 0 | 33 |
2023 March | 22 | 6 | 28 |
2023 February | 23 | 13 | 36 |
2023 January | 26 | 5 | 31 |
2022 December | 39 | 6 | 45 |
2022 November | 64 | 10 | 74 |
2022 October | 34 | 17 | 51 |
2022 September | 56 | 8 | 64 |
2022 August | 39 | 7 | 46 |
2022 July | 16 | 19 | 35 |
2022 June | 18 | 6 | 24 |
2022 May | 14 | 9 | 23 |
2022 April | 21 | 16 | 37 |
2022 March | 17 | 8 | 25 |
2022 February | 20 | 7 | 27 |
2022 January | 11 | 5 | 16 |
2021 December | 18 | 12 | 30 |
2021 November | 17 | 7 | 24 |
2021 October | 21 | 13 | 34 |
2021 September | 13 | 11 | 24 |
2021 August | 10 | 5 | 15 |
2021 July | 8 | 7 | 15 |
2021 June | 17 | 7 | 24 |
2021 May | 16 | 7 | 23 |
2021 April | 36 | 3 | 39 |
2021 March | 14 | 13 | 27 |
2021 February | 8 | 8 | 16 |
2021 January | 13 | 10 | 23 |
2020 December | 1 | 1 | 2 |